For Diabetes Patients Semaglutide may Reduce Smoking Risks

A team of researchersthe National Institutes of Health's National Institute on Drug Abuse and the Case Western Reserve University School of Medicine investigated whether the glucagon-like peptide receptor agonist (GLP-1RA) semaglutide, which has been used to treat obesity and type 2 diabetes mellitus could improve health care measures related to tobacco use disorders.

The Secrets of Treponemal Evolutionary History hold by Ancient Brazilian Genomes

They reconstruct four such ancient genomes and find that the prehistoric treponemal pathogen's most closely related extant relative is Treponema pallidum endemicum, the pathogen responsible for bejel. They reconstruct four such ancient genomes and find that the prehistoric treponemal pathogen's most closely related extant relative is Treponema pallidum endemicum, the pathogen responsible for bejel.

Cross-Reactive Anti-SARS-CoV-2 Antibodies Found to Possess in Feline Coronavirus-Infected Domesticated Cats

Researchers confirmed that feline coronavirus (FCoV) infection induced the production of cross-reactive antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD) in domestic cats, despite minimal sequence amino acid (aa) similarity between RBDs of SARS-CoV-2, and FCoV serotype 1 (FCoV1) and serotype 2 (FCoV2).

Study Shows the Magnitude and Duration of the Protective Effect of Prior Infection and Hybrid Immunity against Omicron Infection and Severe Disease

In a recent study posted, researchers reviewed the duration and magnitude of the protective effect of previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (PE) and hybrid immunity (HE,previous infections and vaccinations) against SARS-CoV-2 Omicron variant of concern (VOC) infections and coronavirus disease 2019 (COVID-19) severity.

Cross-Reactive Immunity against SARS-CoV-2 N Protein was Present in Africa Prior to the Pandemic Indicates in Study

In a recent study published, researchers assessed the pre-existing cross-protective immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein and spike (S) protein before the coronavirus disease 2019 (COVID-19) pandemic in individuals residing in North and South America, Europe and Africa in vitro and in vivo.

Omicron is Severe Compared to Delta

There remains a limited amount of data on the comparative severity of illness among adult inpatients with coronavirus disease 2019 (COVID-19) caused by the Omicron or Delta variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

More Severe Disease Caused by Each SARS-CoV-2 Reinfection

In a recent study and currently posted, researchers at Washington University School of Medicine and VA Saint Louis Health Care System showed that acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection adds to the risks of all-cause mortality and hospitalization accrued during the first SARS-CoV-2 infection.

To Potently Targets the BA.1 and BA.2 Omicron Variants of SARS-CoV-2 an Engineered ACE2 Decoy Receptor can be Administered by Inhalation

Researchers in the United States have shown the inhalation of an angiotensin-converting enzyme 2 (ACE2) decoy receptor, sACE22.v2.4-IgG1, increases survival and ameliorates lung injury in K18-hACE2 transgenic mice infected with a lethal dose of the virulent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gamma variant.

Important Things Related for a Better Sleep

Having a good sleep is what everyone wants, as a better sleep leads to an active body and brain.the type of mattress, one sleeps on and the type of food one consumes to the drink one slurps till lightening of room one sleeps in, there are many things that impact the quality of sleep.

Nipah Virus Outbreak in India Amidst of COVID-19 Pandemic

While the coronavirus disease 2019 (COVID-19) pandemic hit the world with devastating impact, the southern Indian state of Kerala was dealing with it in a firm manner, keeping case counts low enough that the healthcare system was never overwhelmed at any point, while supporting the needs of the economically deprived who had no means of regular income-generating work.

New Research Reveals Pfizer/BioNTech and Oxford/AstraZeneca COVID-19 Vaccine Efficacy and Immune Response in Clinically Vulnerable Individuals

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19) has infected over 221 million and caused the deaths of over 4.57 million as of September 6, 2021. Vaccination against COVID-19 is largely believed to be the only effective method to end the current pandemic.

Over 5,000 New COVID Cases Registered for 2nd Day in a Row in Maharashtra

Maharashtra on Thursday breached the 5,000-mark for the second day in a row with 5,108 new COVID-19 cases and 159 deaths. Mumbai’s saw 398 new cases with seven deaths. The state’s COVID-19 tally has now reached 6,442,788, while the toll stands at 136,730. There are currently 50,393 active cases across the state, of which Pune tops with 13,085 followed by Thane with 7,092, and Satara with 5,381.

Evidence of Sustained Benefits of Pimavanserin for Dementia-Related Psychosis

Up to half of the 45 million people worldwide who are living with Alzheimer's disease will experience psychotic episodes, a figure that is even higher in some other forms of dementia. Psychosis is linked to a faster deterioration in dementia. Despite this, there is no approved safe and effective treatment for these particularly distressing symptoms. In people with dementia, widely-used antipsychotics lead to sedation, falls and increased risk of deaths.

Has the Delta variant of SARS-CoV-2 made herd immunity impossible?

1) Scientists hoped that, following vaccination, populations would develop herd immunity to SARS-CoV-2, reducing the risk of infection, even for people without antibodies against the virus. 2) However, the head of the Oxford Vaccine Group, Prof. Andrew Pollard, says herd immunity is “not a possibility” given how transmissible the Delta variant of SARS-CoV-2 is. 3) Other health experts remain optimistic despite the challenges this rapidly spreading variant poses.